Under-representation of the elderly in cancer clinical trials

Area of Science:

• Geriatric oncology
• Clinical trial methodology
• Cancer research disparities

Background:

• Cancer disproportionately affects individuals over 65.
• Older adults are significantly under-represented in clinical trials for novel cancer therapies.
• This under-representation raises critical questions about the applicability of trial results to the elderly population.

Purpose of the Study:

• To assess the importance of elderly under-representation in cancer clinical trials.
• To identify reasons contributing to this disparity in trial participation.
• To explore potential strategies for improving the inclusion of older adults in cancer treatment research.

Main Methods:

• Review of existing literature on geriatric oncology and clinical trial demographics.
• Analysis of factors influencing participation of elderly patients in clinical research.
• Exploration of best practices and proposed interventions for enhancing recruitment of older adults.

Main Results:

• Under-representation of the elderly in cancer trials is a consistent and significant issue.
• Multiple factors contribute to this disparity, including health status, comorbidities, and trial design.
• Addressing this imbalance is crucial for advancing cancer care tailored to the needs of older patients.

Conclusions:

• The under-representation of elderly individuals in cancer clinical trials poses a significant challenge to evidence-based geriatric oncology.
• Understanding the barriers and implementing targeted strategies are essential to ensure that new cancer treatments are evaluated in, and benefit, the aging population.
• Further research and policy changes are needed to promote equitable participation and improve outcomes for older cancer patients.